What is Rezo Therapeutics?
Headquartered in San Francisco, California, Rezo Therapeutics operates at the intersection of advanced biological research and therapeutic development. The company is dedicated to identifying and validating novel drug targets, utilizing a sophisticated platform designed to address complex disease states. By focusing on high-impact therapeutic areas, Rezo Therapeutics aims to bridge the gap between academic discovery and commercial-grade medical solutions. Its market position is defined by a rigorous scientific methodology and a strategic focus on long-term value creation within the life sciences sector.
How much funding has Rezo Therapeutics raised?
Rezo Therapeutics has raised a total of $78M across 1 funding round:
Series A
$78M
Series A (2022): $78M with participation from SR One, Liquid 2 Ventures, Norwest Venture Partners, and SV Angel
Key Investors in Rezo Therapeutics
SR One
SR One is a transatlantic biotechnology venture capital firm that invests in early and growth-stage life sciences companies developing novel therapeutics, leveraging deep sector expertise to support scientific innovation.
Liquid 2 Ventures
Liquid 2 Ventures is an investment firm that supports exceptional founders by providing capital, community, and strategic mentorship to accelerate the growth of early-stage technology companies.
SV Angel
SV Angel is a long-term investment firm dedicated to supporting founders through strategic insights and a vast network, ensuring companies have the resources necessary to scale effectively.
What's next for Rezo Therapeutics?
Looking ahead, the deployment of the $78M capital will be instrumental in scaling the company's operational infrastructure and expanding its internal pipeline. The strategic focus will likely shift toward optimizing lead candidates and strengthening intellectual property portfolios to ensure a competitive edge in the global biotech market. As the firm matures, the emphasis will remain on achieving key clinical data readouts that validate its therapeutic hypotheses. With the support of its seasoned investor syndicate, Rezo Therapeutics is poised to navigate the complexities of the regulatory environment while continuing to attract top-tier scientific talent to its San Francisco hub.
See full Rezo Therapeutics company page
